If the epidemiologists are unsure how events will play out, then you should be skeptical of any economist that claims to know better, Neil Shearing writes in an essay on finews.first.
This article is published on finews.first, a forum for authors specialized in economic and financial topics.
The rapid spread of the Wuhan virus has forced economists and market participants to confront a series of questions that are almost impossible to answer. The outbreak has the potential to cause severe economic and market dislocation. But the scale of the impact will ultimately be determined by how the virus spreads and evolves, which is almost impossible to predict, as well as how governments respond.
If the epidemiologists are unsure how events will play out, then you should be skeptical of any economist that claims to know better. At this stage, I think there are three useful things we can say about the potential economic and market fallout.
«An economic shock in China is now more likely to spread to the rest of the world»
The first is that, while past epidemics offer some clues about the possible economic impact, the parallels are inexact. At the risk of stating the obvious, no two viruses are the same. The economic backdrop to the current Wuhan virus is also different from previous epidemics. While it’s tempting to draw comparisons to the SARS epidemic in 2003, China’s economy is now much larger and more closely integrated into global supply chains. An economic shock in China is now more likely to spread to the rest of the world.
The market backdrop is also very different. The SARS virus hit at a time when global stock markets were starting to bottom out following the bursting of the dot-com bubble. In contrast, the Wuhan virus has hit ten years into a bull market for equities. With valuations no longer cheap, and in some cases a little stretched, investors are more likely to be looking for an excuse to sell rather than buy. The potential for the virus to trigger a significant market correction is much greater now than it was back then.
«This will have implications for the scale of the impact on the rest of the world»
The second point to make is that the steps to contain the virus – rather than the virus itself – are causing most of the economic damage. It is therefore significant that the response by China’s government has been both faster and more extensive than was the case with SARS. The Lunar New Year holiday has been extended for most of the country, keeping factories and other workplaces shut. Widespread travel restrictions have been imposed, transport services curtailed and tourist groups banned. The scale of the response is perhaps one reason to expect the initial hit to activity to be larger than it was with SARS.
The third point to stress is that economic dislocation caused by the virus will spread across sectors over time, and this will have implications for the scale of the impact on the rest of the world. The initial disruption was concentrated in the travel and tourism sectors. Passenger numbers have fallen by 55 percent compared to the Lunar New Year period in 2019. And given that Chinese tourists spend a lot in Asian countries, the costs of travel bans will be felt throughout the region (particularly Cambodia, Thailand, and Hong Kong).
«So what can we draw from all of this? »
But the disruption is now spreading to the domestic industry, as factories that should have opened on Friday following the New Year holiday remain shut. Given that China is now at the heart of many global supply chains, this will have knock-on effects around the world. Economies in Asia (particularly Vietnam and Taiwan) look most vulnerable but, the bigger the disruption, the higher the chances that it affects economies further afield including commodity producers such as Chile and Australia and manufacturers such as Korea, Japan, and Germany.
So what can we draw from all of this? The best we can infer from past epidemics is that we should expect a significant hit to activity in China in the first quarter of this year followed by a rebound in output once the virus is brought under control. As long as factory closures don’t lead to job losses, by this time next year the level of GDP is unlikely to be very different from what it would have been without the virus. We’ve just cut our forecast for Q1 growth (as measured by our China Activity Proxy) from 5.5 percent y/y to around 3.0 percent y/y but, for now, think the lost output will be made up over the rest of this year
«There are three implications for the rest of the world»
- First, given the size and importance of China’s economy, the impact on the global economy is likely to be more significant than in previous epidemics (including SARS).
- Second, the greater the disruption in China, the more likely it is to spread overseas.
- And third, given that we’re ten years into a global equity bull market, the potential for the virus to trigger a significant market correction is much greater now than it has been during previous epidemics.
This much we know. As things stand, everything else is just speculation. We’ll continue to monitor the spread of the virus and its effect on China’s economy and global markets on a dedicated website.
Neil Shearing is the group chief economist at Capital Economics. He has overall responsibility for managing a team of economists and leading the research, as well as developing the firm’s products and its relationship with clients. He is also a director of the company. Prior to becoming Chief Economist, he was Chief Emerging Markets Economist. He also managed the New York office. He joined the firm from HM Treasury where he worked as an economic adviser in various areas, including fiscal policy and global economics. He holds degrees in Economics from the University of York and the University of London and is a fellow of the Royal Society of Arts.
Previous contributions: Rudi Bogni, Peter Kurer, Oliver Berger, Rolf Banz, Dieter Ruloff, Werner Vogt, Walter Wittmann, Alfred Mettler, Peter Hody, Robert Holzach, Craig Murray, David Zollinger, Arthur Bolliger, Beat Kappeler, Chris Rowe, Stefan Gerlach, Marc Lussy, Nuno Fernandes, Richard Egger, Maurice Pedergnana, Marco Bargel, Steve Hanke, Urs Schoettli, Ursula Finsterwald, Stefan Kreuzkamp, Oliver Bussmann, Michael Benz, Peter Hody, Albert Steck, Martin Dahinden, Thomas Fedier, Alfred Mettler, Brigitte Strebel, Peter Hody, Mirjam Staub-Bisang, Nicolas Roth, Thorsten Polleit, Kim Iskyan, Stephen Dover, Denise Kenyon-Rouvinez, Christian Dreyer, Kinan Khadam-Al-Jame, Robert Hemmi, Anton Affentranger, Yves Mirabaud, Katharina Bart, Frédéric Papp, Hans-Martin Kraus, Gerard Guerdat, Mario Bassi, Stephen Thariyan, Dan Steinbock, Rino Borini, Bert Flossbach, Michael Hasenstab, Guido Schilling, Werner E. Rutsch, Dorte Bech Vizard, Adriano B. Lucatelli, Katharina Bart, Maya Bhandari, Jean Tirole, Hans Jakob Roth, Marco Martinelli, Thomas Sutter, Tom King, Werner Peyer, Thomas Kupfer, Peter Kurer, Arturo Bris, Frederic Papp, James Syme, Dennis Larsen, Bernd Kramer, Ralph Ebert, Armin Jans, Nicolas Roth, Hans Ulrich Jost, Patrick Hunger, Fabrizio Quirighetti, Claire Shaw, Peter Fanconi, Alex Wolf, Dan Steinbock, Patrick Scheurle, Sandro Occhilupo, Will Ballard, Michael Bornhaeusser, Nicholas Yeo, Claude-Alain Margelisch, Jean-François Hirschel, Jens Pongratz, Samuel Gerber, Philipp Weckherlin, Anne Richards, Antoni Trenchev, Benoit Barbereau, Pascal R. Bersier, Shaul Lifshitz, Klaus Breiner, Ana Botín, Martin Gilbert, Jesper Koll, Ingo Rauser, Carlo Capaul, Claude Baumann, Markus Winkler, Konrad Hummler, Thomas Steinemann, Christina Boeck, Guillaume Compeyron, Miro Zivkovic, Alexander F. Wagner, Eric Heymann, Christoph Sax, Felix Brem, Jochen Moebert, Jacques-Aurélien Marcireau, Peter Hody, Ursula Finsterwald, Claudia Kraaz, Michel Longhini, Stefan Blum, Zsolt Kohalmi, Karin M. Klossek, Nicolas Ramelet, Søren Bjønness, Lamara von Albertini, Andreas Britt, Gilles Prince, Fabrizio Pagani, Darren Willams, Salman Ahmed, Stephane Monier, and Peter van der Welle, Beat Wittmann, Ken Orchard, Michael Welti, Christian Gast, Didier Saint-Georges, Jeffrey Bohn, Juergen Braunstein, Jeff Voegeli, Gérard Piasko, Fiona Frick, Jean Keller, Stefan Schneider, Matthias Hunn, Andreas Vetsch, Fabiana Fedeli, Claude Baumann, Marionna Wegenstein, Kim Fournais, Carole Millet, Ralph Ebert, Lars Jaeger, Swetha Ramachandran, Brigitte Kaps, Thomas Stucki, and Teodoro Cocca.
